Clinical Trial Update: Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating hyperimmune plasma from convalescent COVID-19 patients (Phase 1/Phase 2) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov-2

Drugs mentioned

• Hyperimmune plasma from convalescent antibodies

Snippet

Sponsor: Andalusian Network for Design and Translation of Advanced Therapies | Conditions: SARS-CoV 2 | Phase 1, Phase 2 | Status: COMPLETED